Larson S M, Carrasquillo J A
Semin Nucl Med. 1984 Oct;14(4):268-76. doi: 10.1016/s0001-2998(84)80002-1.
New developments in nuclear oncology, based on monoclonal antibodies and position emission tomography measurement of glucose metabolism promise to broaden the range of applications of nuclear medicine methods in the clinical management of patients with tumor. Perhaps of greatest importance, is the prospect of both diagnosing and treating common solid tumors, with the same radiolabeled (monoclonal antibody) pharmaceutical preparation.
基于单克隆抗体和葡萄糖代谢正电子发射断层扫描测量的核肿瘤学新进展有望扩大核医学方法在肿瘤患者临床管理中的应用范围。也许最重要的是，有望使用相同的放射性标记（单克隆抗体）药物制剂来诊断和治疗常见实体瘤。
